Chaque fois qu'Alain Bellemare prend la route de Louiseville, il laisse derri猫re lui son titre de pr茅sident et chef de la direction de Bombardier pour mieux redevenir le fils, le fr猫re, le neveu et...
WB II Acqui颅si颅tion Corp. is pleased to announce that it has entered into a 鈥渢hree-cornered鈥� amal颅ga颅ma颅tion agree颅ment (the 鈥淎mal颅ga颅ma颅tion Agree颅ment鈥�) pur颅suant to the pro颅vi颅sions of The Busi...
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining...
Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the...
Bombardier's new CEO is expected to be on the hot seat next week as he meets for the first time with shareholders who are clamouring for a turnaround plan after enduring a rough year by the...
RSS